Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5866 posts found.

WHO: COVID-19 hospital waste presents health threat

February 1, 2022 Manufacturing and Production

The vast amount of waste produced in tackling the COVID-19 pandemic poses a threat to human and environmental health, warns …
News

FDA grants Evrysdi priority review for treatment of spinal muscular atrophy in infants

January 25, 2022 Manufacturing and Production

The FDA has granted priority review of a supplemental new drug application (sNDA) for Evrysdi (risdiplam), to expand the indication …
News
credit_-_crevis_shutterstock_340710245_720

Significantly reduced tumour growth with new candidate

January 25, 2022 Manufacturing and Production

Spago Nanomedical AB announced new clinical and preclinical results for the company’s leading candidate drug, Tumorad® (177Lu-SN201). In a preclinical …
News

Bimzelx approved in Japan for treatment of multiple types of psoriasis

January 25, 2022 Manufacturing and Production

UCB announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted marketing authorisation for BIMZELX (bimekizumab) for …
News

FDA restrict use of two monoclonal antibody treatments

January 25, 2022 Manufacturing and Production

The FDA has shared that it is limiting the use of two monoclonal antibody therapies for the treatment of COVID-19, …
News

Julie Beeso joins Envision Pharma Group as new Global Director

January 18, 2022 Manufacturing and Production

Envision Pharma Group has appointed Julie Beeso as its Global Director, Professional Development and Engagement. Julie has worked for almost …
Appointment
mario_torchia_ist

Mario Torchia appointed as new Vice President of Sales & Marketing at InSilicoTrials

January 18, 2022 Manufacturing and Production

InSilicoTrials, a leader in simulation software solutions for healthcare, has announced Mario Torchia’s appointment. Torchia recently led the Sales Strategy …
Appointment

Enhertu granted priority review in US for patients with HER2-positive metastatic breast cancer

January 18, 2022 Manufacturing and Production

Enhertu, manufactured by AstraZeneca and Daiichi Sankyo, has been accepted for the treatment of adult patients in the US with …
News

SMC accept Enhertu for the treatment of HER2 positive metastatic breast cancer

January 18, 2022 Manufacturing and Production

Daiichi Sankyo and AstraZeneca have announced that the SMC has accepted Enhertu® for use within NHS Scotland for the treatment …
News
andrei_r_-_shutterstock_1935537274_720

Almirall and IRB Barcelona research for skin disease therapeutics discovery

January 18, 2022 Manufacturing and Production

Almirall and IRB Barcelona (the Institute for Research in Biomedicine) have announced a research collaboration to identify the new oral …
News

Abbisko Therapeutics collaborates with Lilly to discover novel molecules

January 18, 2022 Manufacturing and Production

Abbisko Therapeutics announced that it has entered into a partnership and exclusive licensing agreement with Eli Lilly and Company. This …
News

Latest study shows positive results of CanSinoBIO’s inhaled COVID-19 vaccine as booster

January 11, 2022 Manufacturing and Production

CanSino Biologics has announced that a heterologous booster with one dose of the Inhalation Convidecia for adults aged 18 years …
News

Novartis to seek FDA Emergency Use Approval approval for new COVID-19 therapy

January 11, 2022 Manufacturing and Production

Novartis shared on the 10 January, that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep, has prompted …
News

Largest Phase III hemophilia trial produces positive results

January 11, 2022 Manufacturing and Production

BioMarin Pharmaceutical has revealed positive results from its ongoing Phase III GENEr8-1 trial on the viability of valoctocogene roxaparvovec as …
News

Pfizer’s Omicron vaccine to begin human trials late January

January 11, 2022 Manufacturing and Production

Albert Bourla, the CEO of Pfizer, said a COVID-19 vaccine specifically targeting the Omicron variant of the virus, alongside other …
News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026